Спасибо за Вашу активность, Ваш вопрос будет рассмотрен модераторами в ближайшее время
Introduction of a new law on licensing of medicinal products will not lead to their deficit and price increase, vice Prime Minister Kostiantyn Hryshchenko told a briefing, ForUm correspondent reports.
He explained that the introduction of licensing of medicines is a requirement of time and a normal European practice.
"If we move towards Europe, we need to use European standards," he stressed.
According to Hryshchenko, "laws and regulations that will be adopted to implement them are aimed at ensuring rights and safety of patients," he said and explained that an importer will be responsible for the quality of products. In particular, a resident of Ukraine will have to represent a particular company.
Hryshchenko emphasized that Ukraine has no objective reasons for the shortage of imported drugs due to their licensing.
This information was confirmed by head of the State Service on Drugs Oleksiy Soloviov.
According to him, 2-2.5 - month supply of imported drugs are kept at the pharmaceutical warehouses, including unique drugs for the treatment of oncology, diabetes, etc. The official stressed that the distributors are obliged to create stocks of such products.